US Patent 8883447 Anti-GLP-1R antibodies and their uses

Patent 8883447 was granted and assigned to Janssen Biotech on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Janssen Biotech

Current Assignee

Janssen Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8883447

Patent Inventor Names

Kristen Picha0

Karyn O'Neil0

Date of Patent

November 11, 2014

Patent Application Number

13759526

Date Filed

February 5, 2013

Patent Citations Received

‌

US Patent 11779633 Glucagon-like peptide 1 receptor agonists and uses thereof

‌

US Patent 12090193 Glucagon-like peptide 1 receptor agonists and uses thereof

Patent Primary Examiner

‌

Ruixiang Li

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8883447 Anti-GLP-1R antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API